Northwestern Mutual Wealth Management Co. Has $468,000 Stock Position in Revvity, Inc. (NYSE:RVTY)

Northwestern Mutual Wealth Management Co. lifted its stake in shares of Revvity, Inc. (NYSE:RVTY) by 165.3% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,463 shares of the company’s stock after purchasing an additional 2,781 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in Revvity were worth $468,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Rothschild Investment LLC acquired a new stake in shares of Revvity during the 2nd quarter worth $25,000. Logan Capital Management Inc. acquired a new stake in shares of Revvity during the 4th quarter worth $37,000. EverSource Wealth Advisors LLC grew its holdings in shares of Revvity by 74.2% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 392 shares of the company’s stock worth $41,000 after purchasing an additional 167 shares in the last quarter. Family Firm Inc. bought a new stake in Revvity during the second quarter worth $43,000. Finally, Fairfield Financial Advisors LTD acquired a new stake in shares of Revvity in the 2nd quarter valued at $43,000. 86.65% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

RVTY has been the subject of a number of research analyst reports. Leerink Partnrs raised Revvity to a “strong-buy” rating in a report on Monday, July 8th. Bank of America boosted their target price on Revvity from $118.00 to $127.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 30th. Wells Fargo & Company started coverage on shares of Revvity in a research note on Tuesday, August 27th. They issued an “equal weight” rating and a $130.00 price target on the stock. JPMorgan Chase & Co. upped their price objective on shares of Revvity from $105.00 to $120.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 30th. Finally, Leerink Partners initiated coverage on shares of Revvity in a research report on Monday, July 8th. They issued an “outperform” rating and a $125.00 target price on the stock. Eight analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $125.53.

Insider Buying and Selling at Revvity

In other news, insider Joel S. Goldberg sold 3,500 shares of Revvity stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $117.86, for a total value of $412,510.00. Following the completion of the transaction, the insider now directly owns 33,400 shares of the company’s stock, valued at approximately $3,936,524. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.60% of the company’s stock.

Revvity Stock Down 0.4 %

Shares of RVTY opened at $122.03 on Wednesday. The stock’s 50-day moving average price is $121.68 and its two-hundred day moving average price is $112.01. Revvity, Inc. has a 12 month low of $79.50 and a 12 month high of $128.15. The company has a market capitalization of $15.06 billion, a PE ratio of 100.85, a PEG ratio of 2.90 and a beta of 1.05. The company has a current ratio of 2.27, a quick ratio of 1.98 and a debt-to-equity ratio of 0.40.

Revvity (NYSE:RVTY) last posted its quarterly earnings data on Monday, July 29th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.12 by $0.10. The company had revenue of $691.70 million for the quarter, compared to analyst estimates of $690.33 million. Revvity had a return on equity of 7.34% and a net margin of 6.26%. The firm’s quarterly revenue was down 2.5% on a year-over-year basis. During the same period in the previous year, the firm earned $1.21 earnings per share. On average, analysts anticipate that Revvity, Inc. will post 4.75 EPS for the current year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 8th. Investors of record on Friday, October 18th will be issued a $0.07 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $0.28 annualized dividend and a yield of 0.23%. Revvity’s payout ratio is 23.14%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.